RNA Editing Gordon Research Conference (GRC) Presentation … RNA Editing Gordon Research Conference (GRC) Oral presentation title: Development of RNA editing oligonucleotides technology to address liver … Março 23, 2023
ProQR Update August 2022 Community news … will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple therapeutic … Agosto 11, 2022
ProQR at TIDES to highlight our Axiomer® technology Blog … Conference (TIDES Europe) 2022 to highlight our Axiomer® RNA-editing platform technology. This month several ProQRians … Novembro 17, 2022
Exploring why companies partner their technology Blog … on developing potential medicines using our Axiomer ® RNA editing platform technology. Strategic collaborations … Janeiro 03, 2023
Catching up with returning ProQRian René Beukema Blog In this personal interview, we speak to ProQR’s Chief Corporate Development Officer & General Counsel, René Beukema on his return to ProQR. Fevereiro 09, 2023
ProQR welcomes a new generation of scientists Blog Throughout the year ProQR regularly welcomes student groups from across the Netherlands. Fevereiro 21, 2024
RNA Leaders Europe Congress Presentation ProQR Presentation at RNA Leaders Europe Congress Março 16, 2023
Oligonucleotide and Precision Therapeutics (OPT) Congress Congress … Oral presentation title: Therapeutic potential of an RNA editing platform using Editing Oligonucleotides (EONs) … Março 14, 2023
ProQR Therapeutics Virtual R&D Event 2023 Webcast … event, the Company will showcase its proprietary Axiomer ® RNA-editing technology platform, announce initial pipeline … Março 29, 2023
Today marks an expansion of the ProQR and Lilly partnership News update … on developing potential medicines using our Axiomer RNA editing platform technology. Strategic collaborations … Dezembro 22, 2022
